• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Is pyrazinamide bactericidal against Mycobacterium tuberculosis?

作者信息

Heifets L B, Lindholm-Levy P J

机构信息

National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

出版信息

Am Rev Respir Dis. 1990 Jan;141(1):250-2. doi: 10.1164/ajrccm/141.1.250.

DOI:10.1164/ajrccm/141.1.250
PMID:2105072
Abstract

Bactericidal activity of pyrazinamide (PZA) was tested at pH 5.6 in 7H12 broth against drug-susceptible M. tuberculosis strains. The highest tested concentrations of PZA, 500 and 1,000 micrograms/ml, killed no more than 76% of the bacterial population. These concentrations are more than 32 times greater than the minimal inhibitory concentration (MIC) and the achievable in vivo concentrations. Despite high clinical efficacy of PZA and its so-called sterilizing activity in mouse experiments, this drug is much less bactericidal in vitro than any other known antituberculosis drug.

摘要

相似文献

1
Is pyrazinamide bactericidal against Mycobacterium tuberculosis?
Am Rev Respir Dis. 1990 Jan;141(1):250-2. doi: 10.1164/ajrccm/141.1.250.
2
Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations.吡嗪酰胺对半休眠结核分枝杆菌菌群的体外杀菌活性。
Am Rev Respir Dis. 1992 May;145(5):1223-5. doi: 10.1164/ajrccm/145.5.1223.
3
Rapid radiometric method for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.用于结核分枝杆菌吡嗪酰胺药敏试验的快速放射测量法。
Res Microbiol. 1989 May-Jun;140(4-5):301-9. doi: 10.1016/0923-2508(89)90022-3.
4
Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method.采用放射测量法测定不同pH值下结核分枝杆菌对吡嗪酰胺的最低抑菌浓度。
Antimicrob Agents Chemother. 1988 Jul;32(7):1002-4. doi: 10.1128/AAC.32.7.1002.
5
Does pyrazinoic acid as an active moiety of pyrazinamide have specific activity against Mycobacterium tuberculosis?吡嗪酸作为吡嗪酰胺的活性部分,对结核分枝杆菌是否具有特异性活性?
Antimicrob Agents Chemother. 1989 Aug;33(8):1252-4. doi: 10.1128/AAC.33.8.1252.
6
[A study of the bacteriophage-based assay for the detection of pyrazinamide resistance in Mycobacterium tuberculosis].[基于噬菌体检测结核分枝杆菌对吡嗪酰胺耐药性的研究]
Zhonghua Jie He He Hu Xi Za Zhi. 2006 Sep;29(9):625-8.
7
The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?生长速率对结核分枝杆菌中吡嗪酰胺活性的影响——对早期杀菌活性的启示?
BMC Infect Dis. 2016 May 17;16:205. doi: 10.1186/s12879-016-1533-z.
8
Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide.BacT/ALERT PZA试剂盒与BACTEC 460TB PZA用于检测结核分枝杆菌对吡嗪酰胺敏感性的比较评估。
J Antimicrob Chemother. 2007 Sep;60(3):655-7. doi: 10.1093/jac/dkm252. Epub 2007 Jul 5.
9
Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.异烟肼和乙硫异烟胺对鸟分枝杆菌和结核分枝杆菌的抑菌和杀菌活性比较。
Am Rev Respir Dis. 1991 Feb;143(2):268-70. doi: 10.1164/ajrccm/143.2.268.
10
Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.结核分枝杆菌对吡嗪酰胺的药敏试验。
Zentralbl Bakteriol Mikrobiol Hyg A. 1987 Jul;265(3-4):404-7.

引用本文的文献

1
Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide.抑制宿主 PARP1 有助于吡嗪酰胺的抗炎和抗结核活性。
Nat Commun. 2023 Dec 9;14(1):8161. doi: 10.1038/s41467-023-43937-1.
2
Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update.结核分枝杆菌吡嗪酰胺耐药相关突变:综述与更新。
Curr Microbiol. 2022 Oct 8;79(11):348. doi: 10.1007/s00284-022-03032-y.
3
Mechanisms of Pyrazinamide Action and Resistance.吡嗪酰胺的作用机制与耐药性
Microbiol Spectr. 2013;2(4):1-12. doi: 10.1128/microbiolspec.MGM2-0023-2013.
4
High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis.高内涵筛选技术结合人肉芽肿模型作为评估抗结核药物活性的新方法。
Antimicrob Agents Chemother. 2015 Jan;59(1):693-7. doi: 10.1128/AAC.03705-14. Epub 2014 Oct 27.
5
Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability.耐多药结核病并非由于不遵医嘱,而是由于患者间药代动力学的变异性。
J Infect Dis. 2011 Dec 15;204(12):1951-9. doi: 10.1093/infdis/jir658. Epub 2011 Oct 21.
6
Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.分枝杆菌感染治疗中的药代动力学和药效学问题。
Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):243-55. doi: 10.1007/s10096-004-1109-5. Epub 2004 Mar 13.